Logo image of RCEL

AVITA MEDICAL INC (RCEL) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:RCEL - US05380C1027 - Common Stock

4.14 USD
+0.25 (+6.43%)
Last: 1/22/2026, 1:16:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RCEL revenue by date.RCEL revenue by date.
34.42M
17.76%
50.143M
45.68%
64.251M
28.14%
72.681M
13.12%
92.71M
27.56%
158.91M
71.41%
280.23M
76.35%
349.28M
24.64%
399.51M
14.38%
473.85M
18.61%
577.77M
21.93%
705.83M
22.16%
EBITDA
YoY % growth
RCEL ebitda by date.RCEL ebitda by date.
-26.56M
-3.79%
-41.715M
-57.06%
-54.873M
-31.54%
-41.31M
24.72%
-23.154M
43.95%
-12.75M
44.93%
30.793M
341.51%
37.546M
21.93%
44.093M
17.44%
50.231M
13.92%
56.166M
11.82%
61.996M
10.38%
EBIT
YoY % growth
RCEL ebit by date.RCEL ebit by date.
-27.13M
-3.12%
-42.347M
-56.09%
-55.999M
-32.24%
-43.547M
22.24%
-29.825M
31.51%
-12.206M
59.07%
105.44M
963.84%
150.96M
43.17%
188.21M
24.68%
318.19M
69.06%
408.65M
28.43%
520.52M
27.38%
Operating Margin
RCEL operating margin by date.RCEL operating margin by date.
-78.82%-84.45%-87.16%-59.92%-32.17%-7.68%37.63%43.22%47.11%67.15%70.73%73.75%
EPS
YoY % growth
RCEL eps by date.RCEL eps by date.
-1.07
8.55%
-1.40
-30.84%
-2.39
-70.71%
-1.53
36.05%
-0.88
42.38%
-0.33
62.55%
3.33
1,111.20%
4.28
28.23%
5.25
22.73%
6.66
26.89%
8.60
29.19%
10.89
26.52%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.37
15.62%
-0.30
43.55%
-0.28
25.74%
-0.23
49.00%
-0.21
43.22%
-0.19
35.23%
-0.17
38.55%
-0.10
56.52%
-0.10
51.61%
Revenue
Q2Q % growth
18.195M
-1.15%
19.89M
7.43%
21.386M
16.11%
23.12M
35.51%
25.262M
38.84%
24.48M
23.08%
25.398M
18.76%
24.378M
5.44%
27.336M
8.21%
EBITDA
Q2Q % growth
-6.324M
28.57%
-6.273M
42.94%
-5.814M
40.94%
-5.1M
30.65%
-4.947M
21.77%
N/AN/AN/A7.752M
256.70%
EBIT
Q2Q % growth
-9.594M
3.87%
-8.432M
26.77%
-8.024M
26.51%
-6.358M
29.36%
-5.61M
41.52%
N/AN/AN/A1.836M
132.73%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.46
25.81%
-0.29-0.17-58.80%
Q2 2025
Q2Q % growth
-0.38
36.67%
-0.25-0.13-50.22%
Q1 2025
Q2Q % growth
-0.53
27.40%
-0.39-0.14-34.96%
Q4 2024
Q2Q % growth
-0.44
-57.14%
-0.440.000.41%
Q3 2024
Q2Q % growth
-0.62
-82.35%
-0.45-0.17-39.31%
Q2 2024
Q2Q % growth
-0.60
-46.34%
-0.53-0.07-13.56%
Q1 2024
Q2Q % growth
-0.73
-97.30%
-0.48-0.25-51.24%
Q4 2023
Q2Q % growth
-0.28
-27.27%
-0.380.1026.68%
Q3 2023
Q2Q % growth
-0.34
-54.55%
-0.450.1124.92%
Q2 2023
Q2Q % growth
-0.41
-64.00%
-0.33-0.08-23.91%
Q1 2023
Q2Q % growth
-0.37
2.63%
-0.26-0.11-44.52%
Q4 2022
Q2Q % growth
-0.22
-29.41%
-0.300.0826.20%
Q3 2022
Q2Q % growth
-0.22
15.38%
-0.350.1336.47%
Q2 2022
Q2Q % growth
-0.25
3.85%
-0.400.1537.15%
Q1 2022
Q2Q % growth
-0.38
20.83%
-0.390.011.96%
Q4 2021
Q2Q % growth
-0.17
71.67%
-0.400.2357.54%
Q3 2021
Q2Q % growth
-0.26
63.38%
-0.390.1332.92%
Q2 2021
Q2Q % growth
-0.26
56.67%
-0.290.0311.34%
Q1 2021
Q2Q % growth
-0.48
32.39%
-0.31-0.17-55.57%
Q4 2020
Q2Q % growth
-0.60 -0.44-0.16-35.23%
Q3 2020
Q2Q % growth
-0.71 -0.39-0.32-82.82%
Q2 2020
Q2Q % growth
-0.60 -0.25-0.35-140.10%
RCEL Yearly EPS VS EstimatesRCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
17.062M
-12.71%
18.547M-1.485M-8.01%
Q2 2025
Q2Q % growth
18.418M
21.21%
23.061M-4.643M-20.13%
Q1 2025
Q2Q % growth
18.514M
66.73%
21.565M-3.051M-14.15%
Q4 2024
Q2Q % growth
18.406M
29.67%
21.464M-3.058M-14.25%
Q3 2024
Q2Q % growth
19.546M
43.25%
19.814M-268K-1.35%
Q2 2024
Q2Q % growth
15.195M
29.29%
15.028M167K1.11%
Q1 2024
Q2Q % growth
11.104M
5.25%
11.268M-164K-1.46%
Q4 2023
Q2Q % growth
14.195M
50.05%
14.79M-595K-4.02%
Q3 2023
Q2Q % growth
13.645M
50.11%
13.635M10K0.07%
Q2 2023
Q2Q % growth
11.753M
40.92%
11.547M206K1.78%
Q1 2023
Q2Q % growth
10.55M
39.92%
10.538M12K0.11%
Q4 2022
Q2Q % growth
9.46M
36.31%
8.849M611K6.90%
Q3 2022
Q2Q % growth
9.09M
29.49%
7.173M1.917M26.73%
Q2 2022
Q2Q % growth
8.34M
-19.03%
7.293M1.047M14.36%
Q1 2022
Q2Q % growth
7.54M
-14.03%
6.913M627K9.07%
Q4 2021
Q2Q % growth
6.94M
36.08%
7.14M-200K-2.80%
Q3 2021
Q2Q % growth
7.02M
38.74%
6.881M139.335K2.03%
Q2 2021
Q2Q % growth
10.3M
52.01%
8.043M2.257M28.06%
Q1 2021
Q2Q % growth
8.77M
76.74%
6.883M1.887M27.42%
Q4 2020
Q2Q % growth
5.1M 5.712M-612K-10.71%
Q3 2020
Q2Q % growth
5.06M 4.998M62K1.24%
RCEL Yearly Revenue VS EstimatesRCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -63.9% 0% -41.17%
Revenue0% -21.52% 0% -7.97%